{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Integra LifeSciences Holdings Corp.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 31, 2025, Integra LifeSciences Holdings Corp. shows a mildly bearish trend, driven by bearish daily moving averages and Bollinger Bands, despite a mildly bullish MACD, with a year-to-date return of -49.34% compared to the S&P 500's 16.30%.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 31, 2025, Integra LifeSciences Holdings Corp. is in a mildly bearish trend, indicated by bearish daily moving averages and weekly Bollinger Bands, despite some mildly bullish MACD signals, and has underperformed the S&P 500 with a year-to-date return of -47.05% compared to the S&P's 16.30%.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 31, 2025, Integra LifeSciences Holdings Corp. shows a mildly bearish trend with mixed technical indicators, underperforming the S&P 500 significantly with a year-to-date return of -47.05% compared to the index's 16.30%.
Integra LifeSciences Hits Day Low of $11.05 Amid Price Pressure
Integra LifeSciences Holdings Corp. has faced significant stock volatility, with a notable decline in performance over various timeframes, including a year-to-date drop of nearly 48%. The company is grappling with operational challenges, reflected in reduced cash flow and diminishing stakeholder confidence, amid ongoing struggles in the pharmaceuticals and biotechnology sector.
Integra LifeSciences Hits 52-Week Low at USD 11.05 Amidst Decline
Integra LifeSciences Holdings Corp. has hit a new 52-week low, reflecting a challenging year with a significant stock price decline. The company faces difficulties in growth, evidenced by negative operating profit growth and low operating cash flow. Promoter confidence is also waning, indicating ongoing financial challenges.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 24, 2025, Integra LifeSciences Holdings Corp. shows a mildly bullish technical trend, supported by weekly and monthly MACD indicators, despite mixed signals from daily moving averages and Bollinger Bands, while the stock has outperformed the S&P 500 recently but underperformed over longer periods.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 24, 2025, Integra LifeSciences Holdings Corp. shows a mildly bullish trend supported by weekly and monthly MACD, KST, and OBV indicators, despite daily moving averages indicating caution.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 24, 2025, Integra LifeSciences Holdings Corp. shows a mildly bullish technical trend supported by positive MACD, KST, and OBV indicators, despite short-term bearish moving averages and mixed signals from Bollinger Bands, while it has outperformed the S&P 500 recently but underperformed year-to-date.
Integra LifeSciences Holdings Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics
Integra LifeSciences Holdings Corp. has experienced notable stock fluctuations, with a recent closing price of $14.80. The company faces mixed technical signals and has underperformed compared to the S&P 500, showing significant declines over the past year and year-to-date, indicating challenges in aligning with market trends.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 3, 2025, Integra LifeSciences Holdings Corp. shows a mildly bearish trend, with daily moving averages indicating bearishness, while underperforming the S&P 500 with a year-to-date return of -34.74% compared to its 14.18%.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of October 3, 2025, Integra LifeSciences Holdings Corp. shows a mildly bearish trend, with daily moving averages indicating bearishness, while underperforming the S&P 500 with a year-to-date return of -34.74%.
Integra LifeSciences Hits Day High with 8.73% Surge in Stock Price
Integra LifeSciences Holdings Corp. saw a notable stock increase on September 30, 2025, reaching an intraday high. However, the company has struggled over the past year and year-to-date, with significant declines. Its market capitalization is USD 1,298 million, and key financial metrics indicate challenges in stakeholder confidence.
Integra LifeSciences Holdings Corp. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators
Integra LifeSciences Holdings Corp. has experienced a mixed technical performance, with varying trends across different metrics. The company's stock price is currently at $14.41, reflecting a decline over the past year and year-to-date compared to broader market indices, indicating challenges in maintaining competitive performance.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of September 19, 2025, Integra LifeSciences Holdings Corp. shows a mildly bearish trend influenced by daily moving averages, while weekly indicators suggest mild bullishness, and it has underperformed the S&P 500 with a year-to-date return of -36.46%.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of September 19, 2025, Integra LifeSciences Holdings Corp. shows a mildly bearish trend, with mixed technical indicators and significant underperformance against the S&P 500, posting a year-to-date return of -37.70% compared to the S&P 500's 13.31%.
Integra LifeSciences Hits Day Low of $14.07 Amid Price Pressure
Integra LifeSciences Holdings Corp. faced a notable decline in stock value, reflecting ongoing challenges in the Pharmaceuticals & Biotechnology sector. The company has experienced a significant drop in operating profit and cash flow, while promoter confidence has decreased, indicating difficulties in maintaining growth and market position.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of September 8, 2025, Integra LifeSciences Holdings Corp. is in a neutral trend with mixed indicators, showing mildly bullish signals on the MACD and KST but underperforming the S&P 500 with a year-to-date return of -32.19%.
Is Integra LifeSciences Holdings Corp. overvalued or undervalued?
As of November 4, 2024, Integra LifeSciences Holdings Corp. is considered overvalued and risky, with a P/E ratio of 10 and a year-to-date return of -32.19%, significantly underperforming its peers and the S&P 500.
Is Integra LifeSciences Holdings Corp. technically bullish or bearish?
As of April 11, 2025, the market trend has shifted to bearish, supported by negative signals from the MACD, moving averages, and Bollinger Bands, despite a slight bullish momentum in the weekly RSI.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
